Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 11151-11200 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04994795
Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer
N/AActive, not recruiting
4,000 participants
Started: Aug 21, 2021 · Completed: Feb 28, 2025
1 condition1 sponsor30 locations
NCT04950985
Improving Outcomes of Necrotising Otitis Externa
N/AActive, not recruiting
356 participants
Started: Aug 20, 2021 · Completed: Nov 20, 2024
1 condition1 sponsor1 location
NCT05025176
Hypotension Prediction Index: Correlations Between Invasive and Non-invasive Pressure Points.
N/AActive, not recruiting
50 participants
Started: Aug 20, 2021 · Completed: Aug 20, 2025
1 condition1 sponsor1 location
NCT05020678
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
PHASE1Active, not recruiting
150 participants
Started: Aug 20, 2021 · Completed: Dec 31, 2038
10 conditions1 sponsor6 locations
NCT04790058
CSRS Implementation - A Pilot Study
N/AActive, not recruiting
900 participants
Started: Aug 20, 2021 · Completed: May 1, 2027
1 condition2 sponsors1 location
NCT04751929
Abemaciclib With or Without Atezolizumab for mCRPC
PHASE2Active, not recruiting
19 participants
Started: Aug 20, 2021 · Completed: Dec 20, 2025
2 conditions3 sponsors1 location
NCT06611657
Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
PHASE2Active, not recruiting
40 participants
Started: Aug 20, 2021 · Completed: Jul 30, 2025
1 condition1 sponsor1 location
NCT05156593
'Long COVID-19' in Suffolk and North Essex: Defining the Disease and Optimising Outcomes
N/AActive, not recruiting
350 participants
Started: Aug 20, 2021 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT04637035
Supportive Oncology Care at Home Post-Discharge
NAActive, not recruiting
110 participants
Started: Aug 19, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05008198
Assessing an EEG Biomarker of Response to TMS for Major Depression
N/AActive, not recruiting
266 participants
Started: Aug 19, 2021 · Completed: Sep 30, 2026
1 condition13 sponsors1 location
NCT05231798
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
PHASE2Active, not recruiting
20 participants
Started: Aug 19, 2021 · Completed: Apr 30, 2026
3 conditions2 sponsors1 location
NCT04921137
Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer
PHASE4Active, not recruiting
109 participants
Started: Aug 19, 2021 · Completed: Feb 28, 2029
1 condition1 sponsor7 locations
NCT04877613
GFRα4 CAR T Cells in MTC Patients
PHASE1Active, not recruiting
18 participants
Started: Aug 19, 2021 · Completed: Jun 1, 2039
2 conditions1 sponsor1 location
NCT04923893
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
PHASE3Active, not recruiting
743 participants
Started: Aug 19, 2021 · Completed: Sep 22, 2036
1 condition1 sponsor136 locations
NCT04987359
A Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer
NAActive, not recruiting
54 participants
Started: Aug 19, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05024695
Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
NAActive, not recruiting
975 participants
Started: Aug 19, 2021 · Completed: Jul 31, 2029
1 condition1 sponsor37 locations
NCT04951453
Systemic Nitrosative/Oxidative Stress in Patients with Acute Brain Injury
N/AActive, not recruiting
150 participants
Started: Aug 18, 2021 · Completed: Sep 30, 2025
3 conditions2 sponsors1 location
NCT05499728
Telerehabilitation After Shoulder Arthroplasty
NAActive, not recruiting
93 participants
Started: Aug 18, 2021 · Completed: Aug 31, 2025
3 conditions1 sponsor1 location
NCT05011305
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis with Fibrosis
PHASE2Active, not recruiting
180 participants
Started: Aug 18, 2021 · Completed: Sep 30, 2025
2 conditions1 sponsor152 locations
NCT04263480
Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia
PHASE2Active, not recruiting
99 participants
Started: Aug 18, 2021 · Completed: Aug 31, 2028
1 condition3 sponsors20 locations
NCT04844866
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
PHASE2Active, not recruiting
168 participants
Started: Aug 18, 2021 · Completed: Jul 31, 2029
1 condition2 sponsors53 locations
NCT04717700
Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
PHASE2Active, not recruiting
50 participants
Started: Aug 18, 2021 · Completed: Jun 1, 2029
1 condition3 sponsors11 locations
NCT04976634
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)
PHASE2Active, not recruiting
730 participants
Started: Aug 18, 2021 · Completed: Mar 22, 2027
1 condition1 sponsor57 locations
NCT04971161
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
PHASE2Active, not recruiting
152 participants
Started: Aug 18, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors38 locations
NCT03639753
Transportation Safety in Adolescence
NAActive, not recruiting
2,400 participants
Started: Aug 18, 2021 · Completed: Feb 1, 2026
1 condition6 sponsors1 location
NCT04998370
Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury
N/AActive, not recruiting
409 participants
Started: Aug 18, 2021 · Completed: Oct 31, 2024
4 conditions1 sponsor8 locations
NCT04962126
Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy
PHASE2Active, not recruiting
15 participants
Started: Aug 17, 2021 · Completed: Jul 31, 2025
1 condition4 sponsors3 locations
NCT03991481
The Cryopreserved vs. Liquid Platelets Trial
PHASE3Active, not recruiting
388 participants
Started: Aug 17, 2021 · Completed: Nov 30, 2025
2 conditions2 sponsors6 locations
NCT04335682
Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide
PHASE2Active, not recruiting
111 participants
Started: Aug 17, 2021 · Completed: Aug 31, 2026
6 conditions2 sponsors8 locations
NCT05096091
International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
N/AActive, not recruiting
5,399 participants
Started: Aug 16, 2021 · Completed: Jan 31, 2026
1 condition8 sponsors11 locations
NCT04745234
Mogamulizumab Q4week Dosing in Participants With R/R CTCL
PHASE2Active, not recruiting
34 participants
Started: Aug 16, 2021 · Completed: May 31, 2025
2 conditions1 sponsor16 locations
NCT04775719
Pilot Sensor Randomized Controlled Trial: Setting Expectations to Increase Satisfactory Outcomes After Total Knee Replacement
NAActive, not recruiting
40 participants
Started: Aug 16, 2021 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT04975750
A Problem Solving Intervention Involving Employees at Risk of Sick Leave Due to Common Mental Disorders
NAActive, not recruiting
170 participants
Started: Aug 16, 2021 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT04579692
MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia
NAActive, not recruiting
10 participants
Started: Aug 16, 2021 · Completed: Dec 15, 2025
1 condition3 sponsors1 location
NCT04455698
Engaging and Activating Cancer Survivors in Genetic Services Study
NAActive, not recruiting
391 participants
Started: Aug 16, 2021 · Completed: Dec 31, 2025
1 condition5 sponsors3 locations
NCT05006508
Prevention With the Health and Lifestyle Tool
NAActive, not recruiting
77,000 participants
Started: Aug 16, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05006027
Feasibility of PCI Using a 7-Fr Thin-Walled Sheath Via the DRA
N/AActive, not recruiting
100 participants
Started: Aug 16, 2021 · Completed: Oct 15, 2024
3 conditions3 sponsors2 locations
NCT05112289
A Study to Evaluate White Matter Hyperintensities in Migraine
NAActive, not recruiting
50 participants
Started: Aug 16, 2021 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05768165
High-intensity Interval Exercise in Rheumatoid Arthritis
NAActive, not recruiting
87 participants
Started: Aug 16, 2021 · Completed: Mar 30, 2024
1 condition2 sponsors2 locations
NCT04974398
A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
296 participants
Started: Aug 16, 2021 · Completed: Dec 23, 2026
1 condition1 sponsor56 locations
NCT04601779
INFANT HEALTH- Promoting Mental Health and Healthy Weight in Infancy Through Sensitive Parenting
NAActive, not recruiting
406 participants
Started: Aug 16, 2021 · Completed: Jun 30, 2026
3 conditions5 sponsors1 location
NCT04568759
Effect of a Postural Re-education Intervention Compared to Standard Care on Scoliosis Progression in Adolescent
NAActive, not recruiting
47 participants
Started: Aug 15, 2021 · Completed: Sep 30, 2026
1 condition5 sponsors2 locations
NCT04986930
mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma
PHASE2Active, not recruiting
92 participants
Started: Aug 14, 2021 · Completed: Dec 14, 2025
2 conditions1 sponsor1 location
NCT04552171
Game Plan: Efficacy of a Brief, Web-based Intervention on Alcohol Use and Sexually-transmitted Infections
NAActive, not recruiting
500 participants
Started: Aug 13, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05027789
Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention
NAActive, not recruiting
263 participants
Started: Aug 13, 2021 · Completed: Aug 31, 2026
2 conditions2 sponsors1 location
NCT04722887
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Aug 13, 2021 · Completed: Jul 17, 2025
1 condition1 sponsor6 locations
NCT05052255
RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
120 participants
Started: Aug 13, 2021 · Completed: May 31, 2025
1 condition1 sponsor7 locations
NCT04980885
A Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
PHASE1/PHASE2Active, not recruiting
68 participants
Started: Aug 13, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04535401
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
PHASE1Active, not recruiting
10 participants
Started: Aug 13, 2021 · Completed: Apr 29, 2025
14 conditions1 sponsor10 locations
NCT04720209
Taking AIM at Breast Cancer
NAActive, not recruiting
102 participants
Started: Aug 13, 2021 · Completed: Sep 15, 2026
4 conditions2 sponsors2 locations